Australia's CSL posts 8% rise in H1 profit; raises FY outlook
February 11, 2020 at 16:29 PM EST
Australian biotech company CSL Ltd on Wednesday posted an 8% rise in first-half profit and raised its earnings forecast for the full year, helped by strong demand for its immunoglobulin (IG) products.
